Australian researchers found that older adults who took statins had similar cognitive decline rates and brain volume alterations to those who never took statins. The findings in the Journal of the American College of Cardiology, based on brain scans from 1,037 individuals ages 70 to 90, also associated statin use to 16% and 13% improved cognitive performance among those with genetic Alzheimer's disease risk and those with heart disease, respectively.
Study finds no link between statins, cognitive decline
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.